The big picture: Orchestrated data-driven PR campaigns for both rare disease (Shire) and anesthesiology (Merck), transforming complex medical narratives into compelling stories.
Key initiatives:
1. Shire HAE campaigns:
• In-depth US media landscape analysis
• "Discover HAE" campaign with live graphic artist
• "Family Champion" program
• "Discover HAE" campaign with live graphic artist
• "Family Champion" program
2. Merck Bridion initiatives:
• ReachMD podcast scripting: Anesthesiologist-CRNA dialogue
• Healthcare provider appreciation campaign
• Medical conference coverage
• Healthcare provider appreciation campaign
• Medical conference coverage
By the numbers:
• 89% positive/neutral media sentiment for Shire's HAE treatments
• 2,303 medical professionals engaged with anesthesiology content
• 80% content engagement rate on ReachMD platform
• 89% positive/neutral media sentiment for Shire's HAE treatments
• 2,303 medical professionals engaged with anesthesiology content
• 80% content engagement rate on ReachMD platform
Why it matters: Transformed complex medical data into actionable PR strategies, elevating Shire's position in a competitive rare disease landscape.
Bottom line: Merged rigorous media analysis with creative storytelling to amplify Shire's voice in the evolving HAE treatment narrative.
Shire HAE Media Coverage Analysis - US Market
Shire "Discover HAE" Disease Awareness Event
Shire "Family Champion" Discussion Guide
Merck ReachMD Radio Interview
Merck ReachMD Industry Feature Metrics Reporting
Merck Health Care Provider Appreciation Ad Campaign
